| 000 | 01611 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513031606.0 | ||
| 264 | 0 | _c19950504 | |
| 008 | 199505s 0 0 eng d | ||
| 022 | _a0017-5749 | ||
| 024 | 7 |
_a10.1136/gut.36.3.422 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarcellin, P | |
| 245 | 0 | 0 |
_aAdenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication. _h[electronic resource] |
| 260 |
_bGut _cMar 1995 |
||
| 300 |
_a422-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aDNA Replication |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B _xblood |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xphysiology |
| 650 | 0 | 4 |
_aHepatitis, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aVidarabine Phosphate _xadverse effects |
| 650 | 0 | 4 | _aVirus Replication |
| 700 | 1 | _aPouteau, M | |
| 700 | 1 | _aLoriot, M A | |
| 700 | 1 | _aBoyer, N | |
| 700 | 1 | _aDegos, F | |
| 700 | 1 | _aCalès, P | |
| 700 | 1 | _aBettan, L | |
| 700 | 1 | _aBacq, Y | |
| 700 | 1 | _aCoppére, H | |
| 700 | 1 | _aGrange, J D | |
| 773 | 0 |
_tGut _gvol. 36 _gno. 3 _gp. 422-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.36.3.422 _zAvailable from publisher's website |
| 999 |
_c7534745 _d7534745 |
||